Effect of Phytochemicals From Theobroma Cacao on Mental Energy

NCT ID: NCT01651793

Last Updated: 2018-06-25

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-07-31

Study Completion Date

2014-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine which substances in cocoa produces changes in mental energy. This is a double blind study. The primary outcome measures are performance on tasks of sustained attention (serial subtract, continuous performance test and Bakan task) at pre and 90, 120 and 160 minutes post intervention, energy and fatigue symptoms (profile of mood state), and ratings of motivation to perform cognitive tasks. The assigned interventions are the following:

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Only one prior study has examined the acute influence of cocoa on mental energy. The purpose of this research is to replicate the previous observations and extend research in four ways: 1) start to determine which substance in cocoa responsible for the effect by including several comparison groups, 2) focus on individuals with average or below average symptoms of mental energy and who are not high consumers of fruits, vegetables and other products containing high amounts of flavonoids in order to learn whether people with low energy accrue a greater benefit, and 3) include additional measures of mental energy plausibly influenced by cocoa to better understand the health consequences of cocoa.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mental Fatigue

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Caffeinated cocoa

High flavanol, high theobromine, high caffeine, single dose administration in hot water vehicle

Group Type ACTIVE_COMPARATOR

Caffeinated cocoa

Intervention Type OTHER

70 mg caffeine, 179 mg theobromine, 499 mg flavanols, and 1 packet of Truvia sweetener

Cocoa

High flavanol, high theobromine, low caffeine, single dose administration in hot water vehicle

Group Type ACTIVE_COMPARATOR

Cocoa

Intervention Type OTHER

21 mg caffeine, 179 mg theobromine, 499 mg flavanols, and 1 packet of Truvia sweetener

Caffeine

Low flavanol, low theobromine, high caffeine, single dose administration in hot water vehicle

Group Type ACTIVE_COMPARATOR

Caffeine

Intervention Type OTHER

473 ml brewed water containing 66 mg caffeine, caramel coloring and one packet Truvia sweetener

Placebo

No flavanol, no theobromine, no caffeine, single dose administration in hot water vehicle

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type OTHER

473 ml of brewed water, caramel coloring and one packet Truvia sweetener

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Caffeinated cocoa

70 mg caffeine, 179 mg theobromine, 499 mg flavanols, and 1 packet of Truvia sweetener

Intervention Type OTHER

Cocoa

21 mg caffeine, 179 mg theobromine, 499 mg flavanols, and 1 packet of Truvia sweetener

Intervention Type OTHER

Caffeine

473 ml brewed water containing 66 mg caffeine, caramel coloring and one packet Truvia sweetener

Intervention Type OTHER

Placebo

473 ml of brewed water, caramel coloring and one packet Truvia sweetener

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women and men ages 18-34
* Lower than average feelings of energy (score of \< 13 on Profile of Mood States Vigor scale)

Exclusion Criteria

* Pregnant
* GI tract disorder
* Psychoactive medication use
* Daily consumption of \> 200 mg caffeine
* Body mass index \> 30
* Cigarette smoker
* Allergy to cocoa, chocolate or caffeine
* Frequent consumption of cocoa, chocolate-based products or fruits and vegetable containing flavonoids
Minimum Eligible Age

18 Years

Maximum Eligible Age

34 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Hershey Company

INDUSTRY

Sponsor Role collaborator

University of Georgia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Patrick O'Connor

Professor of Kinesiology

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Patrick O'Connor, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Georgia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Georgia

Athens, Georgia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Study of cocoa-like beverages

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.